1	[	[	O	(	O	15	DEP	-1
2	Inhibitory	Inhibitory	B-NP	JJ	O	3	NMOD	0
3	effect	effect	I-NP	NN	O	15	DEP	0
4	of	of	B-PP	IN	O	3	NMOD	-1
5	adenovirus-mediated	adenovirus-mediated	B-NP	JJ	O	8	NMOD	17	mediated
6	endostatin	endostatin	I-NP	NN	O	8	NMOD	-1
7	gene	gene	I-NP	NN	O	8	NMOD	-1
8	transfer	transfer	I-NP	NN	O	4	PMOD	-1
9	on	on	B-PP	IN	O	3	NMOD	-1
10	transplanted	transplant	B-NP	VBN	O	12	NMOD	19	transplanted
11	lung	lung	I-NP	NN	O	12	NMOD	-1
12	carcinoma	carcinoma	I-NP	NN	O	9	PMOD	-1
13	in	in	B-PP	IN	O	12	NMOD	-1
14	mice	mouse	B-NP	NNS	O	13	PMOD	-1
15	]	]	O	)	O	0	ROOT	-1

1	OBJECTIVE	OBJECTIVE	B-NP	NN	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	To	To	B-VP	TO	O	4	VMOD	-1
4	investigate	investigate	I-VP	VB	O	1	NMOD	-1
5	the	the	B-NP	DT	O	6	NMOD	-1
6	effect	effect	I-NP	NN	O	4	OBJ	16	effect
7	of	of	B-PP	IN	O	6	NMOD	-1
8	adenovirus-mediated	adenovirus-mediated	B-NP	JJ	O	11	NMOD	17	mediated
9	endostatin	endostatin	I-NP	NN	O	11	NMOD	-1
10	gene	gene	I-NP	NN	O	11	NMOD	-1
11	transfer	transfer	I-NP	NN	O	7	PMOD	-1
12	on	on	B-PP	IN	O	6	NMOD	-1
13	transplanted	transplant	B-NP	VBN	O	15	NMOD	19	transplanted
14	lung	lung	I-NP	NN	O	15	NMOD	-1
15	cancer	cancer	I-NP	NN	O	12	PMOD	-1
16	in	in	B-PP	IN	O	6	NMOD	-1
17	mice	mouse	B-NP	NNS	O	16	PMOD	-1
18	and	and	O	CC	O	4	VMOD	-1
19	its	its	B-NP	PRP$	O	20	NMOD	-1
20	mechanism	mechanism	I-NP	NN	O	18	OBJ	0
21	of	of	B-PP	IN	O	20	NMOD	-1
22	action	action	B-NP	NN	O	21	PMOD	0
23	.	.	O	.	O	1	P	-1

1	METHODS	METHODS	B-NP	NNS	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	Transplant	Transplant	B-NP	NN	O	5	NMOD	19	Transplant
4	tumor	tumor	I-NP	NN	O	5	NMOD	-1
5	model	model	I-NP	NN	O	6	SUB	-1
6	was	be	B-VP	VBD	O	1	NMOD	-1
7	induced	induce	I-VP	VBN	O	6	VC	0
8	by	by	B-PP	IN	O	7	VMOD	-1
9	subcutaneous	subcutaneous	B-NP	JJ	O	10	NMOD	-1
10	inoculation	inoculation	I-NP	NN	O	8	PMOD	0
11	of	of	B-PP	IN	O	10	NMOD	-1
12	2	2	B-NP	CD	O	14	NMOD	-1
13	x	x	I-NP	SYM	O	14	AMOD	-1
14	10	10	I-NP	CD	O	24	NMOD	-1
15	(	(	O	(	O	17	DEP	-1
16	6	6	B-NP	CD	O	17	DEP	-1
17	)	)	O	)	O	24	NMOD	-1
18	Lewis	Lewis	B-NP	NNP	O	24	NMOD	-1
19	lung	lung	I-NP	NN	B-cell_type	24	NMOD	-1
20	cancer	cancer	I-NP	NN	I-cell_type	24	NMOD	-1
21	(	(	O	(	I-cell_type	24	NMOD	-1
22	LLC	LLC	B-NP	NN	I-cell_type	24	NMOD	-1
23	)	)	O	)	I-cell_type	24	NMOD	-1
24	cells	cell	B-NP	NNS	I-cell_type	11	PMOD	-1
25	into	into	B-PP	IN	O	7	VMOD	-1
26	the	the	B-NP	DT	O	27	NMOD	-1
27	back	back	I-NP	NN	O	25	PMOD	-1
28	of	of	B-PP	IN	O	27	NMOD	-1
29	C57BL/6	C57BL/6	B-NP	NN	O	30	NMOD	-1
30	mice	mouse	I-NP	NNS	O	28	PMOD	-1
31	.	.	O	.	O	1	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	mice	mouse	I-NP	NNS	O	3	SUB	-1
3	were	be	B-VP	VBD	O	0	ROOT	-1
4	treated	treat	I-VP	VBN	O	3	VC	0
5	by	by	B-PP	IN	O	4	VMOD	-1
6	intratumoral	intratumoral	B-NP	JJ	O	7	NMOD	-1
7	injection	injection	I-NP	NN	O	5	PMOD	0
8	of	of	B-PP	IN	O	7	NMOD	-1
9	2	2	B-NP	CD	O	11	AMOD	-1
10	x	x	I-NP	SYM	O	11	AMOD	-1
11	10	10	I-NP	CD	O	16	NMOD	-1
12	(	(	O	(	O	14	DEP	-1
13	9	9	B-NP	CD	O	14	DEP	-1
14	)	)	O	)	O	11	NMOD	-1
15	pfu	pfu	B-NP	NN	O	16	NMOD	-1
16	Ad-mEndostatin	Ad-mEndostatin	I-NP	NN	O	8	PMOD	-1
17	.	.	O	.	O	3	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	expression	expression	I-NP	NN	O	10	NMOD	9	expression
3	of	of	B-PP	IN	O	2	NMOD	-1
4	endostatin	endostatin	B-NP	NN	B-protein	3	PMOD	-1
5	in	in	B-ADVP	FW	O	2	NMOD	-1
6	situ	situ	I-ADVP	FW	O	5	AMOD	-1
7	and	and	O	CC	O	10	NMOD	-1
8	its	its	B-NP	PRP$	O	10	NMOD	-1
9	maintaining	maintain	I-NP	VBG	O	10	NMOD	0
10	time	time	I-NP	NN	O	11	SUB	-1
11	were	be	B-VP	VBD	O	0	ROOT	-1
12	detected	detect	I-VP	VBN	O	11	VC	0
13	by	by	B-PP	IN	O	12	VMOD	-1
14	immunohistochemistry	immunohistochemistry	B-NP	NN	O	17	NMOD	-1
15	and	and	O	CC	O	17	NMOD	-1
16	Western	Western	B-NP	JJ	O	17	NMOD	-1
17	Blot	Blot	I-NP	NN	O	13	PMOD	-1
18	,	,	O	,	O	12	P	-1
19	respectively	respectively	B-ADVP	RB	O	12	VMOD	-1
20	.	.	O	.	O	11	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	endostatin	endostatin	I-NP	NN	O	3	NMOD	-1
3	level	level	I-NP	NN	O	6	SUB	-1
4	in	in	B-PP	IN	O	3	NMOD	-1
5	serum	serum	B-NP	NN	O	4	PMOD	-1
6	was	be	B-VP	VBD	O	20	VMOD	-1
7	determined	determine	I-VP	VBN	O	6	VC	-1
8	by	by	B-PP	IN	O	7	VMOD	-1
9	ELISA	ELISA	B-NP	NN	O	8	PMOD	-1
10	.	.	O	.	O	6	P	-1
11	The	The	B-NP	DT	O	12	NMOD	-1
12	inhibition	inhibition	I-NP	NN	O	17	NMOD	18	inhibition
13	of	of	B-PP	IN	O	12	NMOD	-1
14	tumor	tumor	B-NP	NN	O	15	NMOD	-1
15	growth	growth	I-NP	NN	O	13	PMOD	4	growth
16	and	and	O	CC	O	17	NMOD	-1
17	changes	change	B-NP	NNS	O	20	SUB	0
18	of	of	B-PP	IN	O	17	NMOD	-1
19	survival	survival	B-NP	NN	O	18	PMOD	0
20	were	be	B-VP	VBD	O	29	VMOD	-1
21	recorded	record	I-VP	VBN	O	20	VC	-1
22	and	and	O	CC	O	29	VMOD	-1
23	the	the	B-NP	DT	O	25	NMOD	-1
24	microvessel	microvessel	I-NP	NN	O	25	NMOD	-1
25	density	density	I-NP	NN	O	29	SUB	-1
26	(	(	O	(	O	28	DEP	-1
27	MVD	MVD	B-NP	NN	O	28	DEP	-1
28	)	)	O	)	O	25	NMOD	-1
29	was	be	B-VP	VBD	O	0	ROOT	-1
30	determined	determine	I-VP	VBN	O	29	VC	-1
31	by	by	B-PP	IN	O	30	VMOD	-1
32	histochemical	histochemical	B-NP	JJ	O	31	PMOD	-1
33	stainingwith	stainingwith	I-NP	NN	O	34	NMOD	-1
34	CD31	CD31	I-NP	NN	B-protein	32	NMOD	-1
35	and	and	I-NP	CC	O	32	NMOD	-1
36	CD105	CD105	I-NP	NN	B-protein	37	NMOD	-1
37	antibodies	antibody	I-NP	NNS	I-protein	32	NMOD	-1
38	.	.	O	.	O	29	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	tumor	tumor	I-NP	NN	O	3	NMOD	-1
3	apoptosis	apoptosis	I-NP	NN	O	4	SUB	5	apoptosis
4	was	be	B-VP	VBD	O	0	ROOT	-1
5	observed	observe	I-VP	VBN	O	4	VC	0
6	by	by	B-PP	IN	O	5	VMOD	-1
7	electron	electron	B-NP	NN	O	8	NMOD	-1
8	microscopy	microscopy	I-NP	NN	O	6	PMOD	-1
9	.	.	O	.	O	4	P	-1

1	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	-1
3	In	In	B-PP	IN	O	13	VMOD	-1
4	comparison	comparison	B-NP	NN	O	3	PMOD	-1
5	with	with	B-PP	IN	O	4	NMOD	-1
6	controls	control	B-NP	NNS	O	5	PMOD	0
7	,	,	O	,	O	13	P	-1
8	intratumoral	intratumoral	B-NP	JJ	O	9	NMOD	-1
9	injection	injection	I-NP	NN	O	13	SUB	0
10	of	of	B-PP	IN	O	9	NMOD	-1
11	Ad-mEndostatin	Ad-mEndostatin	B-NP	NN	O	10	PMOD	-1
12	significantly	significantly	B-ADVP	RB	O	13	VMOD	-1
13	inhibited	inhibit	B-VP	VBD	O	1	NMOD	18	inhibited
14	the	the	B-NP	DT	O	18	NMOD	-1
15	tumor	tumor	I-NP	NN	O	16	NMOD	-1
16	growth	growth	I-NP	NN	O	18	NMOD	4	growth
17	and	and	I-NP	CC	O	18	NMOD	-1
18	metastasis	metastasis	I-NP	NN	O	13	OBJ	14	metastasis
19	,	,	O	,	O	13	P	-1
20	and	and	O	CC	O	13	VMOD	-1
21	prolonged	prolong	B-VP	VBD	O	13	VMOD	17	prolonged
22	the	the	B-NP	DT	O	24	NMOD	-1
23	survival	survival	I-NP	NN	O	24	NMOD	5	survival
24	rate	rate	I-NP	NN	O	21	OBJ	-1
25	of	of	B-PP	IN	O	24	NMOD	-1
26	mice	mouse	B-NP	NNS	O	25	PMOD	-1
27	(	(	O	(	O	32	DEP	-1
28	P	P	B-NP	NN	O	32	DEP	-1
29	less	less	B-ADJP	JJR	O	28	NMOD	-1
30	than	than	B-PP	IN	O	29	AMOD	-1
31	0.05	0.05	B-NP	CD	O	30	PMOD	-1
32	)	)	O	)	O	13	VMOD	-1
33	.	.	O	.	O	1	P	-1

1	Strong	Strong	B-NP	JJ	O	3	NMOD	-1
2	positive	positive	I-NP	JJ	O	3	NMOD	0
3	expression	expression	I-NP	NN	O	6	SUB	9	expression
4	of	of	B-PP	IN	O	3	NMOD	-1
5	mEndostatin	mEndostatin	B-NP	NN	B-protein	4	PMOD	-1
6	was	be	B-VP	VBD	O	0	ROOT	-1
7	seen	see	I-VP	VBN	O	6	VC	-1
8	in	in	B-PP	IN	O	7	VMOD	-1
9	the	the	B-NP	DT	O	11	NMOD	-1
10	tumor	tumor	I-NP	NN	O	11	NMOD	-1
11	tissue	tissue	I-NP	NN	O	8	PMOD	-1
12	after	after	B-PP	IN	O	7	VMOD	-1
13	injection	injection	B-NP	NN	O	12	PMOD	19	injection
14	of	of	B-PP	IN	O	13	NMOD	-1
15	Ad-mEndostatin	Ad-mEndostatin	B-NP	NN	B-protein	14	PMOD	-1
16	,	,	O	,	O	7	P	-1
17	immunhistochemically	immunhistochemically	B-VP	RB	O	18	VMOD	-1
18	ostained	ostaine	I-VP	VBN	O	7	VMOD	-1
19	by	by	B-PP	IN	O	18	VMOD	-1
20	mouse	mouse	B-NP	NN	B-protein	23	NMOD	-1
21	endostatin	endostatin	I-NP	NN	I-protein	23	NMOD	-1
22	monoclonal	monoclonal	I-NP	JJ	I-protein	23	NMOD	-1
23	antibody	antibody	I-NP	NN	I-protein	19	PMOD	-1
24	,	,	O	,	O	6	P	-1
25	while	while	B-SBAR	IN	O	6	VMOD	-1
26	the	the	B-NP	DT	O	28	NMOD	-1
27	control	control	I-NP	NN	O	28	NMOD	0
28	groups	group	I-NP	NNS	O	29	SUB	-1
29	showed	show	B-VP	VBD	O	25	SBAR	-1
30	only	only	B-NP	RB	O	32	AMOD	-1
31	very	very	I-NP	RB	O	32	AMOD	-1
32	low	low	I-NP	JJ	O	35	NMOD	-1
33	expression	expression	I-NP	NN	O	35	NMOD	9	expression
34	or	or	I-NP	CC	O	35	NMOD	-1
35	absence	absence	I-NP	NN	O	29	OBJ	9	absence
36	.	.	O	.	O	6	P	-1

1	Serum	Serum	B-NP	NN	O	3	NMOD	-1
2	endostatin	endostatin	I-NP	NN	O	3	NMOD	-1
3	concentration	concentration	I-NP	NN	O	4	SUB	-1
4	was	be	B-VP	VBD	O	20	VMOD	-1
5	1540	1540	B-NP	CD	O	7	AMOD	-1
6	+/-	+/-	I-NP	SYM	O	7	AMOD	-1
7	560	560	I-NP	CD	O	8	NMOD	-1
8	ng/ml	ng/ml	I-NP	NN	O	17	NMOD	-1
9	at	at	B-PP	IN	O	8	NMOD	-1
10	the	the	B-NP	DT	O	12	NMOD	-1
11	second	second	I-NP	JJ	O	12	NMOD	-1
12	week	week	I-NP	NN	O	9	PMOD	-1
13	of	of	B-PP	IN	O	12	NMOD	-1
14	administration	administration	B-NP	NN	O	13	PMOD	19	administration
15	,	,	O	,	O	17	P	-1
16	the	the	B-NP	DT	O	17	NMOD	-1
17	expression	expression	I-NP	NN	O	20	SUB	9	expression
18	of	of	B-PP	IN	O	17	NMOD	-1
19	endostatin	endostatin	B-NP	NN	O	18	PMOD	-1
20	diminished	diminish	B-VP	VBD	O	0	ROOT	18	diminished
21	a	a	B-NP	DT	O	22	NMOD	-1
22	month	month	I-NP	NN	O	20	OBJ	-1
23	later	later	B-ADVP	RB	O	20	VMOD	-1
24	.	.	O	.	O	20	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	microvessel	microvessel	I-NP	NN	O	3	NMOD	-1
3	density	density	I-NP	NN	O	8	SUB	-1
4	(	(	O	(	O	6	DEP	-1
5	MVD	MVD	B-NP	NN	O	6	DEP	-1
6	)	)	O	)	O	3	NMOD	-1
7	)	)	O	)	O	3	NMOD	-1
8	decreased	decrease	B-VP	VBD	O	0	ROOT	18	decreased
9	from	from	B-PP	IN	O	8	VMOD	-1
10	42.4	42.4	B-NP	CD	O	12	AMOD	-1
11	+/-	+/-	I-NP	SYM	O	12	AMOD	-1
12	4.8	4.8	I-NP	CD	O	9	PMOD	-1
13	to	to	I-NP	TO	O	8	VMOD	-1
14	10.5	10.5	I-NP	CD	O	16	AMOD	-1
15	+/-	+/-	I-NP	SYM	O	16	AMOD	-1
16	3.2	3.2	I-NP	CD	O	13	PMOD	-1
17	per	per	B-PP	IN	O	8	VMOD	-1
18	x	x	B-NP	SYM	O	20	AMOD	-1
19	200	200	B-NP	CD	O	20	AMOD	-1
20	magnificetion	magnificetion	I-NP	NN	O	22	NMOD	-1
21	microscopic	microscopic	I-NP	JJ	O	22	NMOD	-1
22	field	field	I-NP	NN	O	17	PMOD	-1
23	by	by	B-PP	IN	O	8	VMOD	-1
24	CD10	CD10	B-NP	NN	B-protein	25	NMOD	-1
25	staining	staining	I-NP	NN	O	23	PMOD	0
26	and	and	B-PP	CC	O	23	PMOD	-1
27	from	from	B-PP	IN	O	23	PMOD	-1
28	68.5	68.5	B-NP	CD	O	30	AMOD	-1
29	+/-	+/-	I-NP	SYM	O	30	AMOD	-1
30	4.5	4.5	I-NP	CD	O	27	PMOD	-1
31	to	to	I-NP	TO	O	8	VMOD	-1
32	37.5	37.5	I-NP	CD	O	34	NMOD	-1
33	+/-	+/-	I-NP	SYM	O	34	NMOD	-1
34	4.6	4.6	I-NP	CD	O	31	PMOD	-1
35	by	by	B-PP	IN	O	31	VMOD	-1
36	CD31	CD31	B-NP	NN	B-protein	37	NMOD	-1
37	staining	staining	I-NP	NN	O	35	PMOD	0
38	,	,	O	,	O	8	P	-1
39	respectively	respectively	B-ADVP	RB	O	8	VMOD	-1
40	(	(	O	(	O	45	DEP	-1
41	P	P	B-NP	NN	O	45	DEP	-1
42	less	less	B-ADJP	JJR	O	41	NMOD	-1
43	than	than	B-PP	IN	O	42	AMOD	-1
44	0.05	0.05	B-NP	CD	O	43	PMOD	-1
45	)	)	O	)	O	8	VMOD	-1
46	.	.	O	.	O	8	P	-1

1	More	More	B-NP	RBR	O	2	AMOD	-1
2	apoptotic	apoptotic	I-NP	JJ	B-cell_type	4	NMOD	5	apoptotic
3	tumor	tumor	I-NP	NN	I-cell_type	4	NMOD	-1
4	cells	cell	I-NP	NNS	I-cell_type	5	SUB	-1
5	were	be	B-VP	VBD	O	0	ROOT	-1
6	seen	see	I-VP	VBN	O	5	VC	-1
7	under	under	B-PP	IN	O	6	VMOD	-1
8	the	the	B-NP	DT	O	11	NMOD	-1
9	transmission	transmission	I-NP	NN	O	11	NMOD	-1
10	electron	electron	I-NP	NN	O	11	NMOD	-1
11	microscope	microscope	I-NP	NN	O	7	PMOD	-1
12	.	.	O	.	O	5	P	-1

1	CONCLUSION	CONCLUSION	B-NP	NN	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	Endostatin	Endostatin	B-NP	NN	O	5	NMOD	-1
4	gene	gene	I-NP	NN	O	5	NMOD	-1
5	therapy	therapy	I-NP	NN	O	11	SUB	0
6	mediated	mediate	B-VP	VBN	O	5	NMOD	17	mediated
7	by	by	B-PP	IN	O	6	VMOD	-1
8	adenoviral	adenoviral	B-NP	JJ	O	9	NMOD	-1
9	vector	vector	I-NP	NN	O	7	PMOD	-1
10	efficiently	efficiently	B-ADVP	RB	O	11	VMOD	-1
11	induces	induce	B-VP	VBZ	O	1	NMOD	17	induces
12	expression	expression	B-NP	NN	O	11	OBJ	9	expression
13	of	of	B-PP	IN	O	12	NMOD	-1
14	endostatin	endostatin	B-NP	NN	B-protein	13	PMOD	-1
15	in	in	B-ADVP	FW	O	11	VMOD	-1
16	vivo	vivo	I-ADVP	FW	O	15	AMOD	-1
17	,	,	O	,	O	11	P	-1
18	and	and	O	CC	O	11	VMOD	-1
19	inhibits	inhibit	B-VP	VBZ	O	11	VMOD	18	inhibits
20	the	the	B-NP	DT	O	23	NMOD	-1
21	growth	growth	I-NP	NN	O	23	NMOD	4	growth
22	and	and	I-NP	CC	O	23	NMOD	-1
23	metastasis	metastasis	I-NP	NN	O	19	OBJ	14	metastasis
24	of	of	B-PP	IN	O	23	NMOD	-1
25	tumor	tumor	B-NP	NN	O	24	PMOD	-1
26	.	.	O	.	O	1	P	-1

1	It	It	B-NP	PRP	O	2	SUB	-1
2	is	be	B-VP	VBZ	O	0	ROOT	-1
3	concluded	conclude	I-VP	VBN	O	2	VC	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	its	its	B-NP	PRP$	O	6	NMOD	-1
6	action	action	I-NP	NN	O	7	SUB	16	action
7	is	be	B-VP	VBZ	O	4	SBAR	-1
8	targeted	target	I-VP	VBN	O	7	VC	0
9	to	to	B-PP	TO	O	8	VMOD	-1
10	tumor	tumor	B-NP	NN	O	11	NMOD	-1
11	neovasculature	neovasculature	I-NP	NN	O	14	NMOD	-1
12	and	and	O	CC	O	14	NMOD	-1
13	the	the	B-NP	DT	O	14	NMOD	-1
14	mechanism	mechanism	I-NP	NN	O	9	PMOD	0
15	is	be	B-VP	VBZ	O	4	DEP	-1
16	inhibition	inhibition	B-NP	NN	O	15	PRD	18	inhibition
17	of	of	B-PP	IN	O	16	NMOD	-1
18	tumor	tumor	B-NP	NN	O	19	NMOD	-1
19	angiogenesis	angiogenesis	I-NP	NN	O	17	PMOD	3	angiogenesis
